Trials / Recruiting
RecruitingNCT07186413
A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris
A Multicenter, Randomized, Double-blinded, Parallel-group, Vehicle-controlled Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 561 (estimated)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to assess the efficacy of trifarotene 50 microgram per gram (mcg/g) cream versus vehicle cream when applied once daily (QD) for 12 weeks in Chinese participants with moderate facial and truncal acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trifarotene | Trifarotene cream applied QD topically. |
| DRUG | Vehicle Cream | Vehicle cream applied QD topically. |
Timeline
- Start date
- 2025-09-23
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-09-22
- Last updated
- 2025-11-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07186413. Inclusion in this directory is not an endorsement.